We Are a "CUT" Above the Rest
We are harnessing advanced biotechnology, combined with tissue engineering and process development to bring tasteful and delicious meats to the table.
Our meats are distinct in that they are “structured meats” like steaks, pork chops and chicken breasts. Unstructured meats have ambiguous forms, such as chicken nuggets or meat balls. Our technology has the capability to achieve the more complex challenge of manufacturing structured meat. Collateral benefits of our technology include clean air, clean water, and a pristine environment.
Our Lab Collaboration
Big Resources; Big Results
Atelier Meats has set up a multidisciplinary R&D collaboration with top experts at Rutgers University to bring together advanced technologies in tissue engineering, cell culture, and process development.
Atelier Meats also brings its own expertise in tissue engineering, process development, quality systems integration to accelerate progress from the bench to the dinner table.
Our Intellectual Property
We have filed a broad patent application to protect key aspects of our technology:
Source and composition of our scaffolds.
Methods of producing our scaffolds
Use of our scaffolds to produce textured meat
Methods for isolation of cells and re-population of our scaffolds with them
Source of the unique bovine stem cells, the isolation and expansion methods of those cells
Composition of the bovine stem cells as defined by unique cell surface markers
Methods of differentiation of those multipotent bovine stem cells
Methods of re-population of scaffolds with differentiated bovine cells
Methods for production of nonhuman mammalian cultured meat fit for human consumption
We have filed a second patent to protect key aspects of the stem cells used for the production of our meats:
CEO of Atelier
Kelsey possesses over 20 years of experience founding, scaling and operating innovative companies across Canada and the Caribbean. She has built multiple 8-figure businesses from the ground up and has twice been named Canada’s Top Female Entrepreneur. Also an accomplished keynote speaker and published author, Kelsey holds an MBA from the Richard Ivey School of Business at the University of Western Ontario.
CFO of Atelier
After starting his career at Goldman Sachs in London and on Wall Street, Nilesh transitioned to hedge fund investments. He has experience in the capital markets and a keen interest in risk assessment. Fluent in four languages, he graduated first in his class with a Master of Engineering from the University of Birmingham and McGill University. He earned his MBA at the University of Alberta in 2015, and he received his Chartered Financial Analyst (CFA) designation in 2017.
Dr. Mohit Bhatia
CSO & Co-Founder
Mohit Bhatia received his Ph.D. in biochemistry from New York University and completed his post-doctoral training at the Rockefeller University in New York as well as Harvard Medical School in Boston, MA. He worked with Celgene Corporation for over 20 years and holds several patents for placental biomaterials. Dr. Bhatia has published several papers and presented at leading conferences around the world for tissue-based therapies.
COO & Co-Founder
Maghsoud has over 35 years of diverse and progressive management experience in the development, scale-up, and commercialization of products in the pharmaceutical and food industries. A biochemical engineer, he has a sound grasp of science and technology required for successful commercialization of cultured meats.
Team Atelier at Rutgers University
Dr. Joseph W. Freeman
Biomedical Engineering Professor
Dr. Joseph W. Freeman is a Professor in the Department of Biomedical Engineering at Rutgers University. After earning his B.S.E. in Chemical Engineering from Princeton University and his PhD in Biomedical Engineering from Rutgers University, Dr. Freeman trained as a postdoctoral fellow at the University of Virginia focusing on bone and ligament tissue engineering. From there, Dr. Freeman became an Assistant Professor in the School of Biomedical Engineering and Sciences at Virginia Tech. There he developed technologies for the repair and tissue engineered replacement of bone and ligament and novel in vitro cancer models. In 2010, Dr. Freeman joined the faculty of Rutgers University where he has continued his work and added research projects in muscle health and muscle tissue engineering. He has over seventy publications in peer-reviewed journals, has authored one book, edited one book, and is an inventor on one patent. Dr. Freeman earned the Outstanding Engineering Faculty Award in 2020, is on the editorial board of several engineering journals, and is a fellow of the American Institute for Medical and Biological Engineering (AIMBE). Over his 18 year career, Dr. Freeman has worked with government agencies, foundations, and industry in the creation of novel systems for tissue engineering. He brings this wealth of experience to Atelier to create quality, textured meats from unique engineered constructs.
Dr. Yong Mao
Chemistry & Chemical Biology Associate Research Professor
Dr. Yong Mao is an associate research professor in the Department of Chemistry and Chemical Biology at Rutgers University. After receiving her Ph.D. training in molecular biology and biochemistry from Rutgers University, Dr. Mao started her research career as a postdoctoral fellow at Princeton University focusing on the cell-extracellular matrix (ECM) interaction and the assembly and application of ECM. Dr. Mao expanded her expertise in ECM as a senior scientist at LifeCell Corporation before joining New Jersey Center for Biomaterials at Rutgers University as a research faculty in 2013. Since then, she has led the biological studies of ECM-polymer biomaterials and cultivated collaborations with industry on multiple translational research projects. She has made noteworthy contributions to the understanding of the tissue ECM and its potentials in tissue regeneration and wound healing. Dr. Mao lectures courses on ECM for undergraduates and graduates at Rutgers University. She has over forty peer-reviewed scientific publications and is an inventor for four US patents. With over 20 years research in ECM and ECM-mediated tissue regeneration both in academia and industry, Dr. Mao brings her expertise to this project to develop textured scaffolds using decellularized tissue ECM and sustainable cell sources from both primary and stem cells.
Capital Markets Advisory Team
Jonathan Gilbert has over 20 years of leadership, capital raising and public markets expertise. He successfully co-founded and managed several companies, leading to multiple successful exits. Previously, he was the co-founder, CEO and director of SOL Global Investments Corp. (formerly Scythian Biosciences Corp.), a publicly traded research and development company. He was also founder, CEO and a director of Tassili Life Sciences Corp., which was acquired by CSE-listed Champignon Brands Inc.
Mr. Rajwani has built and financed public companies and private businesses for over 22 years. He spent several years as the CCO of top-rated boutique advisory firms with a primary focus on risk mitigation.
Senta Capital Advisors
CFO & Strategic Advisor
Senta Capital Advisors specializes in investment banking, compliance and financial & regulatory services. Senta provides expert advice including strategic planning, HR, risk mitigation
Michael is an accomplished leader and entrepreneur in the psychedelics and cannabis industry, co-founding and acting as a director of several companies that successfully completed M&A transactions. He holds a Bachelors's in Computer Science from London University, is a Chartered Engineer and private pilot. Since January 2009, he has been the Managing Director of Eyvo eProcurement Solutions, a US-based private company that is a leading eProcurement provider in the SaaS space. He also runs a business mentoring program that assists businesses and individuals with change management. Mike was co-founder and director of Eleusian Biosciences Corp., which was acquired by Lobe BioSciences in July 2020 where he also joined the Main Board in January 2021.
He also co-founded and was a director of Tassili Life Sciences Corp. which was acquired by CSE-listed Champignon Brands Inc. in March 2020. Mr. Petter has independent board experience being chairman of a compensation committee and as a member of an audit committee. His executive advisory skills focus on providing guidance on strategy, operations, finance and logistics.